The Law Firm of Levi & Korsinsky, LLP Announces Investigation of Tiens Biotech Group (USA), Inc.
27 Giugno 2011 - 7:44PM
Business Wire
Levi & Korsinsky is investigating the Board of Directors of
Tiens Biotech Group (USA), Inc. (“Tiens Biotech” or “the Company”)
(AMEX: TBV) for possible breaches of fiduciary duty and other
violations of state law in connection with the receipt of a merger
proposal from the Company’s Chairman and CEO, Jinyuan Li. Under the
terms of the transaction, Tiens Biotech shareholders would receive
$1.72 per share of Tiens Biotech stock they own. Mr. Li currently
owns more than 95% of the Company’s outstanding shares.
Click here to learn how to join the action:
http://www.zlk.com/tiens-biotech, or call: 877-363-5972.
The investigation concerns whether the Tiens Biotech Board of
Directors is adequately shopping the Company and taking the
necessary steps to obtain the best possible price for Tiens Biotech
shareholders. In particular, Tiens Biotech reported a book value of
$2.67 per share for the most recent quarter.
If you own common stock in Tiens Biotech and wish to obtain
additional information, please contact Joseph E. Levi, Esq. either
via email at jlevi@zlk.com or by telephone at (212) 363-7500,
toll-free: (877) 363-5972, or visit http://www.zlk.com.
Levi & Korsinsky has expertise in prosecuting investor
securities litigation and extensive experience in actions involving
financial fraud and represents investors throughout the nation,
concentrating its practice in securities and shareholder
litigation. The attorneys at Levi & Korsinsky have been
appointed by numerous courts throughout the country to serve as
lead counsel on behalf of shareholders in major litigations
involving mergers and acquisitions. For more information, please
feel free to contact any of the attorneys listed below. Attorney
advertising. Prior results do not guarantee similar outcomes.
Grafico Azioni Tiens Biotech GR Usa (AMEX:TBV)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Tiens Biotech GR Usa (AMEX:TBV)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Tiens Biotech Grp. (Usa) Common Stock (Borsa Americana (AMEX)): 0 articoli recenti
Più Levi & Korsinsky, LLP Articoli Notizie